Associated Papers
Genetic association of plasminogen activator inhibitor-1 gene polymorphisms (rs2227631 and rs6092) with susceptibility to oral premalignant disorders in a South Indian cohort.
Subbiah U et al.
Oral and Maxillofacial Surgery, 2025
Spontaneous miscarriage driven by maternal genetic mutation at position of PAI-1-844G/A: shed light on a race-specific genetic polymorphism.
Ameri A et al.
Bmc Research Notes, 2023
Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort.
Choi GH et al.
International Journal of Molecular Sciences, 2023
Association between TAFI and PAI-1 polymorphisms with biochemical and hemostatic parameters in polycystic ovary syndrome.
Albuquerque JC et al.
Archives of Gynecology and Obstetrics, 2023
Livedoid vasculopathy and its association with genetic variants: A systematic review.
Gao Y et al.
International Wound Journal, 2021
Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women.
Jamshidi M et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 2021
The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population.
Park HS et al.
Journal of Personalized Medicine, 2020
Association between Single Nucleotide Polymorphisms and Glioma Risk: A Systematic Literature Review.
Tavares CB et al.
Cancer Investigation, 2020
Livedoid vasculopathy: does hyperhomocysteinaemia play an aetiological role?
Marsch WC et al.
European Journal of Dermatology : Ejd, 2019
Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X et al.
Molecular Neurobiology, 2017
Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women.
Kim JO et al.
International Journal of Molecular Sciences, 2016
SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.
Xu X et al.
The Journal of International Medical Research, 2016
Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.
Ozolina A et al.
Bmc Anesthesiology, 2015
4G/5G and A-844G Polymorphisms of Plasminogen Activator Inhibitor-1 Associated with Glioblastoma in Iran--a Case-Control Study.
Pooyan H et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2015
Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G promoter polymorphism with risk of keloid in a Chinese Han population.
Wang Y et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2014
Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K et al.
American Journal of Reproductive Immunology (new York, N.y. : 1989), 2013
Mediators of chronic inflammation in polycystic ovarian syndrome.
Deligeoroglou E et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2012
Val17Ile single nucleotide polymorphisms similarly as Ala15Thr could be related to the lower secretory dynamics of PAI-1 secretion: theoretical evidence.
Jankun J et al.
Current Molecular Medicine, 2011
Allele-specific transcription of the PAI-1 gene in human astrocytes.
Hultman K et al.
Thrombosis and Haemostasis, 2010
Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N et al.
Genetic Testing and Molecular Biomarkers, 2010
The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
Lin S et al.
Endocrine, 2009
Plasminogen activator inhibitor-1 4G/5G gene polymorphism in women with fetal loss.
Ghosh K et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 2009
Association of a polymorphic variant of the adiponectin gene with insulin resistance in african americans.
Specchia C et al.
Clinical and Translational Science, 2008
Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 -675 4G/5G polymorphism in angiographied coronary patients.
Saely CH et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2008
Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response.
Tsai SJ et al.
Pharmacogenetics and Genomics, 2008
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.
Morange PE et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
Plasminogen-activator inhibitor-1 polymorphisms are associated with obesity and fat distribution in the Quebec Family Study: evidence of interactions with menopause.
Bouchard L et al.
Menopause (new York, N.y.), 2005
PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population.
Lopes C et al.
Diabetologia, 2003
Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with pre-eclampsia.
Pegoraro RJ et al.
Acta Obstetricia Et Gynecologica Scandinavica, 2003
Polymorphisms in the TAFI gene and the risk of venous thrombosis.
Kostka H et al.
Clinical Laboratory, 2003
The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.
Morange PE et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
Plasminogen activator inhibitor type 1 (PAI-1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in young Asian Indians with acute myocardial infarction.
Pegoraro RJ et al.
Cardiovascular Journal of South Africa : Official Journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners, 0